You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | -265.4% | -297.2% |
| ROCE | 0.0% |
| Latest | Forecast | |
|---|---|---|
| P/E | -7.7 | 0.0 |
| PEG | 0.0 | -999,999.0 |
| Price / Revenue | 21.6 | 39.9 |
| Price / Book value | 2.5 |
| Latest | Forecast | |
|---|---|---|
| Revenue | -30.8% | 0.0% |
| PBT | 0.0% | n/a |
| EPS | 0.0% | 0.0% |
| DPS | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2017-06-30 | n/a | -12.15 | -17.81p | -7.3 | 0.0 | n/a | n/a | 0.0% |
| 2018-06-30 | 0.07 | -16.91 | -26.52p | -7.0 | 0.0 | n/a | n/a | 0.0% |
| 2019-06-30 | 1.04 | -14.40 | -19.68p | -1.6 | 0.0 | n/a | n/a | 0.0% |
| 2020-06-30 | 6.31 | -5.28 | -4.30p | -7.2 | 0.0 | n/a | n/a | 0.0% |
| 2021-06-30 | 4.37 | -11.54 | -7.30p | -8.8 | 0.0 | n/a | n/a | 0.0% |
| Diurnal agrees special protocol with FDA for Chronocort study Sharecast News | 12 Jul |
|---|---|
| Diurnal gets UK approval for 'Efmody' treatment Sharecast News | 02 Jul |
| Diurnal granted European patent for Alkindi Sharecast News | 23 Apr |
| Director Dealings | 15-Sep-21 09:17 |
|---|---|
| Results for the year ended 30 June 2021 | 14-Sep-21 07:00 |
| Commercial launch of Efmody in the UK | 13-Sep-21 07:00 |
| Diurnal launches Efmody in Germany and Austria | 01-Sep-21 07:00 |
| Grant of Deferred Share Awards | 02-Aug-21 07:01 |